| Website | liquidia.com |
| @Liquidia_Inc | |
| Category | BioTech |
| Phone | 919-328-4400 |
| info@liquidia.com | |
| Employees | |
| Founded | 2004 |
| Description | Material Science |
| TOTAL | $44M |
| FUNDING TOTAL | $44M |
| Series A, 6/06 Wakefield Group Firelake Capital Management Siemens Venture Capital | $6M |
| Grant, 12/09 National Institute of Standards and Technology (NIST) | $3M |
| Series C, 1/10 Canaan Partners Pappas Ventures New Enterprise Associates Firelake Capital Management Morningside Venture Investments | $20M |
| Series C, 7/10 Canaan Partners Pappas Ventures New Enterprise Associates Morningside Group Firelake Capital Management | $5M |
| Venture Round, 3/11 The Bill & Melinda Gates Foundation | $10M |
Liquidia Technologies, Inc., a nanotechnology company, designs, develops, and manufactures precisely engineered particles and films for applications in life and materials science sectors. It develops micro and nanoparticles for the delivery of biological and small molecule therapeutics, as well as for the development of vaccines and inhaled therapeutics in the life sciences sector. The company also develops nano-patterned optical films for displays, lighting, photovoltaics, and related applications in the material science sector.
Liquidia Technologies, Inc. was founded in 2004 and is based in Research Triangle Park, North Carolina.